Published in Biotech Business Week, November 24th, 2003
Genitope has granted the underwriters the right to purchase up to an additional 555,000 shares of common stock to cover over allotments, if any. All of such shares are being offered by Genitope Corp.
WR Hambrecht + Co. is acting as the lead underwriter of the offering. Punk, Ziegel & Co. and Brean Murray & Co., Inc., are acting as comanagers.
Genitope Corp. is a biotechnology company focused on the research and development of novel immunotherapies for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.